Literature DB >> 25578447

Expression quantitative trait Loci acting across multiple tissues are enriched in inherited risk for coronary artery disease.

Hassan Foroughi Asl, Husain A Talukdar, Alida S D Kindt, Rajeev K Jain, Raili Ermel, Arno Ruusalepp, Khanh-Dung H Nguyen, Radu Dobrin, Dermot F Reilly, Heribert Schunkert, Nilesh J Samani, Ingrid Braenne, Jeanette Erdmann, Olle Melander, Jianlong Qi, Torbjörn Ivert, Josefin Skogsberg, Eric E Schadt, Tom Michoel, Johan L M Björkegren.   

Abstract

BACKGROUND: Despite recent discoveries of new genetic risk factors, the majority of risk for coronary artery disease (CAD) remains elusive. As the most proximal sensor of DNA variation, RNA abundance can help identify subpopulations of genetic variants active in and across tissues mediating CAD risk through gene expression. METHODS AND
RESULTS: By generating new genomic data on DNA and RNA samples from the Stockholm Atherosclerosis Gene Expression (STAGE) study, 8156 cis-acting expression quantitative trait loci (eQTLs) for 6450 genes across 7 CAD-relevant tissues were detected. The inherited risk enrichments of tissue-defined sets of these eQTLs were assessed using 2 independent genome-wide association data sets. eQTLs acting across increasing numbers of tissues were found increasingly enriched for CAD risk and resided at regulatory hot spots. The risk enrichment of 42 eQTLs acting across 5 to 6 tissues was particularly high (≤7.3-fold) and confirmed in the combined genome-wide association data from Coronary Artery Disease Genome Wide Replication And Meta-Analysis Consortium. Sixteen of the 42 eQTLs associated with 19 master regulatory genes and 29 downstream gene sets (n>30) were further risk enriched comparable to that of the 153 genome-wide association risk single-nucleotide polymorphisms established for CAD (8.4-fold versus 10-fold). Three gene sets, governed by the master regulators FLYWCH1, PSORSIC3, and G3BP1, segregated the STAGE patients according to extent of CAD, and small interfering RNA targeting of these master regulators affected cholesterol-ester accumulation in foam cells of the THP1 monocytic cell line.
CONCLUSIONS: eQTLs acting across multiple tissues are significant carriers of inherited risk for CAD. FLYWCH1, PSORSIC3, and G3BP1 are novel master regulatory genes in CAD that may be suitable targets.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  coronary artery disease; expression quantitative trait locus; genetics

Mesh:

Substances:

Year:  2015        PMID: 25578447     DOI: 10.1161/CIRCGENETICS.114.000640

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  26 in total

Review 1.  Genome-wide significant loci: how important are they? Systems genetics to understand heritability of coronary artery disease and other common complex disorders.

Authors:  Johan L M Björkegren; Jason C Kovacic; Joel T Dudley; Eric E Schadt
Journal:  J Am Coll Cardiol       Date:  2015-03-03       Impact factor: 24.094

2.  A GTPase-activating protein-binding protein (G3BP1)/antiviral protein relay conveys arteriosclerotic Wnt signals in aortic smooth muscle cells.

Authors:  Bindu Ramachandran; John N Stabley; Su-Li Cheng; Abraham S Behrmann; Austin Gay; Li Li; Megan Mead; Julia Kozlitina; Andrew Lemoff; Hamid Mirzaei; Zhijian Chen; Dwight A Towler
Journal:  J Biol Chem       Date:  2018-04-06       Impact factor: 5.157

Review 3.  Developing Peripheral Blood Gene Expression-Based Diagnostic Tests for Coronary Artery Disease: a Review.

Authors:  Brian Rhees; James A Wingrove
Journal:  J Cardiovasc Transl Res       Date:  2015-06-25       Impact factor: 4.132

Review 4.  HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology.

Authors:  Robert S Rosenson; H Bryan Brewer; Philip J Barter; Johan L M Björkegren; M John Chapman; Daniel Gaudet; Daniel Seung Kim; Eric Niesor; Kerry-Anne Rye; Frank M Sacks; Jean-Claude Tardif; Robert A Hegele
Journal:  Nat Rev Cardiol       Date:  2017-08-10       Impact factor: 32.419

Review 5.  Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis: JACC Macrophage in CVD Series (Part 2).

Authors:  Kathryn J Moore; Simon Koplev; Edward A Fisher; Ira Tabas; Johan L M Björkegren; Amanda C Doran; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2018-10-30       Impact factor: 24.094

6.  Regulation of Stress Granule Formation by Inflammation, Vascular Injury, and Atherosclerosis.

Authors:  Allison B Herman; Milessa Silva Afonso; Sheri E Kelemen; Mitali Ray; Christine N Vrakas; Amy C Burke; Rosario G Scalia; Kathryn Moore; Michael V Autieri
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-29       Impact factor: 8.311

7.  Prediction of Causal Candidate Genes in Coronary Artery Disease Loci.

Authors:  Ingrid Brænne; Mete Civelek; Baiba Vilne; Antonio Di Narzo; Andrew D Johnson; Yuqi Zhao; Benedikt Reiz; Veronica Codoni; Thomas R Webb; Hassan Foroughi Asl; Stephen E Hamby; Lingyao Zeng; David-Alexandre Trégouët; Ke Hao; Eric J Topol; Eric E Schadt; Xia Yang; Nilesh J Samani; Johan L M Björkegren; Jeanette Erdmann; Heribert Schunkert; Aldons J Lusis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-08-20       Impact factor: 8.311

8.  Contribution of Gene Regulatory Networks to Heritability of Coronary Artery Disease.

Authors:  Lingyao Zeng; Husain A Talukdar; Simon Koplev; Chiara Giannarelli; Torbjörn Ivert; Li-Ming Gan; Arno Ruusalepp; Eric E Schadt; Jason C Kovacic; Aldons J Lusis; Tom Michoel; Heribert Schunkert; Johan L M Björkegren
Journal:  J Am Coll Cardiol       Date:  2019-06-18       Impact factor: 24.094

Review 9.  From Loci to Biology: Functional Genomics of Genome-Wide Association for Coronary Disease.

Authors:  Sylvia T Nurnberg; Hanrui Zhang; Nicholas J Hand; Robert C Bauer; Danish Saleheen; Muredach P Reilly; Daniel J Rader
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

10.  Thymoquinone reduces spinal cord injury by inhibiting inflammatory response, oxidative stress and apoptosis via PPAR-γ and PI3K/Akt pathways.

Authors:  Yinming Chen; Benlong Wang; Hai Zhao
Journal:  Exp Ther Med       Date:  2018-04-16       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.